- Report
- March 2024
- 132 Pages
Global
From €944EUR$950USD£785GBP
- Report
- March 2024
- 132 Pages
Global
From €944EUR$950USD£785GBP
- Report
- March 2024
- 132 Pages
Global
From €944EUR$950USD£785GBP
- Report
- February 2024
- 132 Pages
Global
From €944EUR$950USD£785GBP
- Report
- February 2024
- 132 Pages
Global
From €944EUR$950USD£785GBP
- Report
- December 2023
- 132 Pages
Global
From €944EUR$950USD£785GBP
- Report
- July 2022
- 132 Pages
Global
From €844EUR$850USD£702GBP
- Report
- December 2021
- 132 Pages
Global
From €844EUR$850USD£702GBP
- Book
- November 2018
- 492 Pages
- Book
- June 2018
- 184 Pages
- Report
- June 2023
- 390 Pages
Global
From €3547EUR$3,570USD£2,949GBP
- Report
- January 2023
- 710 Pages
Global
From €3547EUR$3,570USD£2,949GBP
- Report
- October 2022
- 250 Pages
Global
From €3547EUR$3,570USD£2,949GBP
- Report
- October 2022
- 310 Pages
Global
From €3815EUR$3,840USD£3,172GBP
- Report
- October 2022
- 286 Pages
Global
From €3547EUR$3,570USD£2,949GBP
- Report
- September 2022
- 200 Pages
Global
From €3547EUR$3,570USD£2,949GBP
- Report
- September 2022
- 299 Pages
Global
From €3547EUR$3,570USD£2,949GBP
- Report
- September 2022
- 263 Pages
Global
From €3547EUR$3,570USD£2,949GBP
The Pharmaceutical Intermediates market is a segment of the pharmaceutical industry that focuses on the production of intermediate compounds used in the manufacture of drugs. These intermediates are typically produced in bulk and are used in the synthesis of active pharmaceutical ingredients (APIs). Pharmaceutical intermediates are typically produced in large quantities and are used in the production of a wide range of drugs, including antibiotics, antifungals, antivirals, and anti-inflammatory agents.
The Pharmaceutical Intermediates market is highly competitive, with many companies offering a wide range of products. Some of the major players in the market include Merck, Pfizer, Novartis, Sanofi, and GlaxoSmithKline. These companies are involved in the production of a variety of intermediates, including amino acids, peptides, carbohydrates, and lipids. Additionally, many of these companies are involved in the development of new intermediates for the production of novel drugs. Show Less Read more